4//SEC Filing
Ross Michael Jay 4
Accession 0001415889-22-006746
CIK 0001840233other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:30 PM ET
Size
5.5 KB
Accession
0001415889-22-006746
Insider Transaction Report
Form 4
ROSS MICHAEL JAY
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-15+13,200→ 13,200 totalExercise: $2.28Exp: 2032-06-14→ Common Stock (13,200 underlying)
Footnotes (1)
- [F1]The option award was granted on June 15, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 15, 2023 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a director of the Issuer through the vesting date.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001254452
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:30 PM ET
- Size
- 5.5 KB